GSK Korea sponsored symposia for Avandamet

Published: 2004-03-12 06:56:00

Updated: 2004-03-12 06:56:00

GSK Korea said it has sponsored symposia in commemoration of launching in Korea of Avandamet tablet (rosiglitazone maleate + metformin), type 2 diabetes medication, from next month.

For more convenient prescription for patients Avandamet tablet (2mg/500mg, 4mg/500mg) is the first and only combination pill that directly targets insulin resistance an underlying cause of type 2 diabetes while...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.